Efficacy of Empagliflozin in Slowing the Progression of Renal Disease in Patients with Type 2 Diabetes: Single-Blind Interventional Study with Placebo Control at Tertiary Care Setting Quetta. L&S [Internet]. 2025 Oct. 8 [cited 2026 Oct. 17];6(4):06. Available from: https://lifenscience.org/index.php/life-and-science/article/view/870